Purpose of the company: Development, manufacturing, and distribution of medical high-tech devices in the field of defibrillator technology — the devices sold under the PRIMEDIC brand are among the global market leaders in this field.
Adress: Rheinwaldstr. 22 78628 Rottweil Deutschland
Local court: 70190 Stuttgart
Register number: HRB470187
The average total assets of company Metrax GmbH over the last 7 years is 9.262.212,96 €.
The company Metrax GmbH as of the reporting date 2022 a bank balance of approx. 1.801.640,78 €. That is -42,85 % less than the average bank balance in the industry of companies with this total assets.
The equity ratio of Metrax GmbH is 40,51 % in the year 2022. In total, that ist 5.826.133,00 €.
The average absolute change in liquidity of the company Metrax GmbH compared to the previous year amounts to 247.907,14 €. That means that the liquidity of the company has increased or decreased by this amount per year on average.
The cash flow of the company Metrax GmbH amounts to 1.487.442,81 € in the year 2022.
The publication dates refer to the date on which the company published its annual financial statements in the company register. This information can provide important insights into the management of the company.
The information presented here comes from publicly accessible sources, in particular the Unternehmensregister, in which companies are obliged to disclose their annual financial statements (Sections 325 et seq. of the German Commercial Code (HGB)).
All key financial figures are based on the companies' published annual financial statements. The information is analysed automatically by Bonscore, without content processing or interpretation.
Please note that despite the utmost care, no guarantee can be given that the information provided is up-to-date, complete or correct.